Stocks · Healthcare · Biotechnology
Enanta Pharmaceuticals, Inc. ENTA
$12.60 -2.78% Close, Oct 5, 2026 · NASDAQ · Market cap $376.9M
Next earnings report: Nov 16, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin widened to -90.0% from -149.4% a year earlier.
- The diluted share count rose 36.4% in a year.
- The stock is in a downtrend: below its 200-day average, with the 50-day average below the 200-day.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 6, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 31%
- Revenue growth, 3-year CAGRBottom 12%
- Revenue growth accelerationBottom 21%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 48%
- Gross marginTop 9%
- Operating marginBottom 30%
- Accruals (lower is better)Top 37%
- Interest coverBottom 42%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 34%
- Free-cash-flow yieldBottom 38%
- EBITDA / enterprise valueBottom 37%
- Sales / enterprise valueBottom 42%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 40%
- 6-month returnBottom 37%
- 1-year return vs S&P 500Top 42%
- Distance from 52-week highTop 41%
- Trend checklist (0–4)Bottom 13%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 50%
- Consecutive EPS beatsBottom 20%
- Share of analysts rating BuyBottom 44%
- Upside to consensus price targetBottom 50%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 25%
- Maximum drawdown, 3 yearsBottom 41%
- Beta vs S&P 500 (lower is better)Bottom 28%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 7.4% | 0.7% | ↓ |
| Gross margin | 100.0% | 98.1% | ↓ |
| Operating margin | -149.4% | -90.0% | ↑ |
| FCF margin | -67.2% | -56.6% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 0.7% | 7.4% | ↓ | Bottom 31% |
| Gross margin | 98.1% | 100.0% | ↓ | Top 9% |
| Operating margin | -90.0% | -149.4% | ↑ | Bottom 30% |
| Net margin | -96.9% | -142.0% | ↑ | — |
| Free-cash-flow margin | -56.6% | -67.2% | ↑ | — |
| Return on invested capital | -23.8% | — | Bottom 48% | |
| Revenue growth, 3-year CAGR | -8.8% | — | Bottom 12% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -9.4%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 23.4%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -22.5 pp
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -4.5×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -18.76%
- Shareholder yield
- -18.76%
- Share count change, 1 year
- +36.4%
- Share count change, 3-year CAGR
- +11.4%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 12, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 5 of 8
- Average EPS surprise, last 4
- +4.0%
- Average 2-day reaction, last 8
- +0.7%
- Positive 20 days after report
- 6 of 8
Analysts
- Consensus price target
- $20.00
- Target vs current price
- +58.7%
- Analysts with a rating
- 19
- Share rating Buy or Strong Buy
- 74%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 10, 2026 | -31.5% | +0.3% | -4.4% | +2.3% | — |
| May 11, 2026 | +2.2% | +0.8% | -12.6% | -27.8% | -13.8% |
| Feb 9, 2026 | +22.2% | +2.4% | +2.5% | +2.8% | +7.2% |
| Nov 17, 2025 | +23.0% | +6.3% | +5.6% | +23.3% | +14.8% |
| Aug 11, 2025 | +32.0% | -5.9% | +15.9% | +29.1% | +56.8% |
| May 12, 2025 | -1.9% | +5.3% | +9.1% | +42.3% | +35.1% |
| Feb 10, 2025 | +9.5% | +0.0% | +45.7% | +38.2% | +3.1% |
| Nov 25, 2024 | -17.2% | -3.5% | -8.2% | -31.8% | -10.7% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 10, 2026 | -$0.67 | -$0.51 | -31.5% | $14.4M |
| May 11, 2026 | -$0.45 | -$0.46 | +2.2% | $17.2M |
| Feb 9, 2026 | -$0.42 | -$0.54 | +22.2% | $18.6M |
| Nov 17, 2025 | -$0.87 | -$1.13 | +23.0% | $15.1M |
| Aug 11, 2025 | -$0.85 | -$1.25 | +32.0% | $18.3M |
| May 12, 2025 | -$1.06 | -$1.04 | -1.9% | $14.9M |
| Feb 10, 2025 | -$1.05 | -$1.16 | +9.5% | $17.0M |
| Nov 25, 2024 | -$1.36 | -$1.16 | -17.2% | $67.6M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 6.12× | — | — | Bottom 42% |
| Free-cash-flow yield | -9.80% | — | — | Bottom 38% |
| Earnings yield | -19.13% | — | — | Bottom 34% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -3.5%
- 200-day average slope (20 days)
- -0.9%
- Distance from 50-day average
- -3.8%
- Distance from 200-day average
- -6.6%
- RSI (14)
- 47.2
- Relative volume
- 0.74×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 42.4%
- Volatility vs own 5-year history
- 7th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.61
- Correlation with S&P 500
- 0.34
- Current drawdown from 1-year high
- -25.2%
- Maximum drawdown, 3 years
- -75.6%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Nov 5, 2021 | Apr 10, 2025 | -95.6% | 859 days | Not yet recovered |
| Feb 8, 2021 | Jul 22, 2021 | -25.4% | 114 days | 26 days (Aug 27, 2021) |
| Nov 11, 2020 | Dec 1, 2020 | -13.3% | 13 days | 27 days (Jan 11, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $376.9M
- EPS, diluted (TTM)
- -$2.41
- Revenue (TTM)
- $65.3M
- 52-week range
- $10.12 – $17.15
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $97.1M | $86.2M | $79.2M | $67.6M | $65.3M |
| Gross profit | $97.1M | $86.2M | $79.2M | $67.6M | $60.7M |
| Operating income | -$109.6M | -$123.8M | -$137.2M | -$121.7M | -$85.3M |
| Net income | -$79.0M | -$121.8M | -$133.8M | -$116.0M | -$81.9M |
| EPS (diluted) | -$3.92 | -$5.91 | -$6.38 | -$5.48 | -$3.84 |
| Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $14.6M | $17.0M | $14.9M | $18.3M | $15.1M | $18.6M | $17.2M | $14.4M |
| Net income | -$28.8M | -$22.3M | -$22.6M | -$18.3M | -$18.7M | -$11.9M | -$13.1M | -$19.5M |
| EPS (diluted) | -$1.36 | -$1.05 | -$1.06 | -$0.86 | -$0.87 | -$0.42 | -$0.45 | -$0.67 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$70.0M | -$84.8M | -$103.2M | -$78.8M | -$19.3M |
| Capital expenditure | -$750,000 | -$2.1M | -$9.1M | -$17.9M | -$12.9M |
| Free cash flow | -$70.7M | -$86.9M | -$112.2M | -$96.7M | -$32.2M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $3.6M | $21.3M | $2.2M | $147,000 | $145,000 |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $189.5M
- Total assets
- $296.9M
- Total liabilities
- $195.8M
- Total debt
- $55.7M
- Net debt
- $22.2M
- Shareholders’ equity
- $101.1M
As of Jun 30, 2026 (filed Aug 12, 2026).
Short interest
- Shares sold short
- 2,600,199
- Days to cover
- 10.72
- Change vs previous report
- -0.6%
FINRA short interest, settlement date Sep 15, 2026.